Giuseppe Nappi

Giuseppe Nappi

Auto-generated profile, based on publicly available information

Giuseppe Nappi

Headache Science Centre, IRCCS Mondino Foundation, Pavia, Italy

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 June 2018 in Cephalalgia
Verified
Journal Article
Open access
SBSara Bottiroli
Sara Bottiroli
MAMarta Allena
Marta Allena
GSGrazia Sances
Grazia Sances
RIRoberto De Icco
Roberto De Icco
MAMicol Avenali
Micol Avenali
TCthe COMOESTAS Consortium
the COMOESTAS Consortium
To identify factors that may be predictors of the outcome of a detoxification treatment in medication-overuse headache. Consecutive patients entering a detoxification program in six centres in Europe and Latin America were evaluated and followed up for 6 months. We evaluated anxious and depressive symptomatology (though patients with severe psychiatric comorbidity were excluded), quality of life, headache-related disability, headache characteristics, and prophylaxis upon discharge. Of the 492 patients who completed the six-month follow up, 407 ceased overuse following the detoxification (non overusers), another 23 ceased overuse following detoxification but relapsed during the follow-up. In the 407 non-overusers, headache acquired an episodic pattern in 287 subjects (responders). At the multivariate analyses, lower depression scores (odds ratio = 0.891; p = 0.001) predicted ceasing overuse. The primary headache diagnosis – migraine with respect to tension-type headache (odds ratio = 0.224; p = 0.001) or migraine plus tension-type headache (odds ratio = 0.467; p = 0.002) – and the preventive treatment with flunarizine (compared to no such treatment) (odds ratio = 0.891; p = 0.001) predicted being a responder. A longer duration of chronic headache (odds ratio = 1.053; p = 0.032) predicted relapse into overuse. Quality of life and disability were not associated with any of the outcomes. Though exploratory in nature, these findings point to specific factors that are associated with a positive outcome of medication-overuse headache management, while identifying others that may be associated with a negative outcome. Evaluation of the presence/absence of these factors may help to optimize the management of this challenging groups of chronic headache sufferers.

26 April 2004 in Journal of Neurochemistry
Verified
Journal Article
Open access
PDF file
Mauro MaccarroneMauro Maccarrone
Mauro Maccarrone
SPSilvia Piccirilli
Silvia Piccirilli
Natalia BattistaNatalia Battista
Natalia Battista
CDClaudio Del Duca
Claudio Del Duca
GNGiuseppe Nappi
Giuseppe Nappi
Giacinto BagettaGiacinto Bagetta
Giacinto Bagetta
Human immunodeficiency virus type‐1 coat glycoprotein gp120 causes delayed apoptosis in rat brain neocortex. Here, we investigated the possible role of the endocannabinoid system in this process. It is shown that gp120 causes a time‐dependent increase in the activity and immunoreactivity of the anandamide (AEA)‐hydrolyzing enzyme fatty acid amide hydrolase (FAAH), paralleled by increased activity of the AEA membrane transporter and decreased endogenous levels of AEA. The AEA‐synthesizing phospholipase D and the AEA‐binding receptors were not affected by gp120. None of the changes induced by gp120 in the cortex were induced by bovine serum albumin, nor were they observed in the hippocampus of the same animals. Also, the activity of 5‐lipoxygenase, which generates AEA derivatives able to inhibit FAAH, decreased down to approximately 25% of the control activity upon gp120 treatment, due to reduced protein level (∼45%). In addition, the FAAH inhibitor methyl‐arachidonoyl fluorophosphonate significantly reduced gp120‐induced apoptosis in rat brain neocortex, whereas selective blockers of AEA membrane transporter or of AEA‐binding receptors were ineffective. Taken together, these results suggest that gp120, by activating FAAH, decreases endogenous levels of AEA, and the latter effect seems instrumental in the execution of delayed neuronal apoptosis in the brain neocortex of rats.

1 November 1998 in Cephalalgia
Verified
Journal Article
Closed access
ACAe Castellano
Ae Castellano
GMG Micieli
G Micieli
PBP Bellantonio
P Bellantonio
MBMg Buzzi
Mg Buzzi
SMS Marcheselli
S Marcheselli
GNG Nappi
G Nappi

1 June 1997 in Clinical Drug Investigation
Verified
Journal Article
Closed access
PDF file
GNGiuseppe Nappi
Giuseppe Nappi
GBGiorgio Bono
Giorgio Bono
PMPaola Merlo
Paola Merlo
ABAlessandro Borromei
Alessandro Borromei
CCCarlo Caltagirone
Carlo Caltagirone
ABAngelo Battaglia
Angelo Battaglia

1 September 2002 in Neurological Sciences
Verified
Journal Article
Closed access
PDF file
EME. Martignoni
E. Martignoni
RNRossella Nappi
Rossella Nappi
ACA. Citterio
A. Citterio
DCD. Calandrella
D. Calandrella
ECE. Corengia
E. Corengia
GNG. Nappi
G. Nappi